Eagle Strategies LLC Sells 561 Shares of iShares Biotechnology ETF $IBB

Eagle Strategies LLC cut its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 12,239 shares of the financial services provider’s stock after selling 561 shares during the period. Eagle Strategies LLC’s holdings in iShares Biotechnology ETF were worth $1,548,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Bar Harbor Wealth Management raised its position in iShares Biotechnology ETF by 1.8% in the second quarter. Bar Harbor Wealth Management now owns 15,568 shares of the financial services provider’s stock valued at $1,970,000 after purchasing an additional 276 shares during the last quarter. Valmark Advisers Inc. raised its position in iShares Biotechnology ETF by 5.7% in the second quarter. Valmark Advisers Inc. now owns 2,573 shares of the financial services provider’s stock valued at $326,000 after purchasing an additional 139 shares during the last quarter. Berkshire Money Management Inc. bought a new position in iShares Biotechnology ETF in the second quarter valued at about $28,000. DAVENPORT & Co LLC raised its position in iShares Biotechnology ETF by 5.9% in the second quarter. DAVENPORT & Co LLC now owns 15,618 shares of the financial services provider’s stock valued at $1,976,000 after purchasing an additional 869 shares during the last quarter. Finally, Grimes & Company Inc. bought a new position in shares of iShares Biotechnology ETF during the second quarter worth about $2,298,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $151.99 on Thursday. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $153.01. The business has a 50-day moving average of $140.21 and a 200-day moving average of $130.36.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were given a dividend of $0.0828 per share. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.